Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Hauser

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Nature Communications|February 23, 2021
Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxisFrédérique Hovaguimian, Huldrych F Günthard, Christoph Hauser, et al.
Open Forum Infectious Diseases|July 16, 2019
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in SwitzerlandGalia M A Santos, Isabella Locatelli, Mélanie Métral, et al.
AIDS (London, England)|August 19, 2021
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIVJosé Damas, Bruno Ledergerber, Isaure Nadin, et al.
International Journal of STD & AIDS|February 25, 2021
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in SwitzerlandGalia Santos, Isabella Locatelli, Mélanie Métral, et al.
SAGE Open Medicine|February 4, 2025
Medium- to long-term health condition of patients post-COVID-19, exercise intolerance and potential mechanisms: A narrative review and perspectiveFabian Schwendinger, Denis Infanger, Debbie J Maurer, et al.
Plos One|March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in SwitzerlandKatharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
Allergy|September 30, 2020
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation studyDaniel Brigger, Michael P Horn, Luke F Pennington, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
Open Forum Infectious Diseases|March 4, 2015
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort StudyBarbara Hasse, Martin Iff, Bruno Ledergerber, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Nature Communications|February 23, 2021
Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxisFrédérique Hovaguimian, Huldrych F Günthard, Christoph Hauser, et al.
Open Forum Infectious Diseases|July 16, 2019
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in SwitzerlandGalia M A Santos, Isabella Locatelli, Mélanie Métral, et al.
AIDS (London, England)|August 19, 2021
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIVJosé Damas, Bruno Ledergerber, Isaure Nadin, et al.
International Journal of STD & AIDS|February 25, 2021
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in SwitzerlandGalia Santos, Isabella Locatelli, Mélanie Métral, et al.
SAGE Open Medicine|February 4, 2025
Medium- to long-term health condition of patients post-COVID-19, exercise intolerance and potential mechanisms: A narrative review and perspectiveFabian Schwendinger, Denis Infanger, Debbie J Maurer, et al.
Plos One|March 2, 2021
Alcohol consumption and neurocognitive deficits in people with well-treated HIV in SwitzerlandKatharine E A Darling, Isabella Locatelli, Nadia Benghalem, et al.
Allergy|September 30, 2020
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation studyDaniel Brigger, Michael P Horn, Luke F Pennington, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
Open Forum Infectious Diseases|March 4, 2015
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort StudyBarbara Hasse, Martin Iff, Bruno Ledergerber, et al.
Pageof 7